Blog

APPEARED IN THE STREET JUNE, 2016   When it comes to fixed-income investments, the devil is in the details, especially when a credit event such as a default is approaching. Because the specter of default is omnipresent in the high-yield bond market, investors who trade these securities scour...

APPEARED IN MARKETWATCH  JULY, 2016. BY STREET DILIGENCE.  With its stock dropping below $20 from a peak of $263.81, the bleak outlook for Valeant Pharmaceuticals International Inc. is largely priced into its stock, but its bonds have yet to catch up. Valeant VRX, +1.10%  bonds are currently...